Abstract:Aim: To search for the novel angiotensin II (A II )AT1 receptor antagonists with high potency and long duration. Methods: By use of telmisartan, a potent non-peptide AT1 receptor antagonist, as a lead compound and the optimized results of ligand-receptor complex modelling, N-phenylpyrrole with an acid group spacer was compared to the biphenyl hearing an acid group spacer which might provide optimal stereo electronic characteristics. Therefore, 12 dibenzimidazoles bearing N-phenyl-1H-pyrrole moiety were designed and synthesized by the replacement of the biphenyl tetrazole with N-phenyl-1H-pyrrole-2-tetrazole and replacement of the tetrazole group with a carboxylic acid moiety, meanwhile introducing different substitutes at the positions-2 of the dibenzimidazole ring and the pyrrole ring. On the other hand, their biological activities were evaluated for antagonism of A II -induced contractions in the rabbit thoracic rings. Results: None of the target compounds has been reported and their structures were identified by IR, 1H NMR, MS spectra and elemental analysis. And the biological activities were evaluated for antagonism of A II-induced contractions in the rabbit thoracic aortic rings. The results of preliminary pharmacological tests showed that compound I d was more potent than telmisartan. Conclusion: I d is worthy to be intensively investigated further.

Synthesis and biological activity evaluation of AT1 angiotensin II receptor antagonists of dibenzimidazoles with N-phenyl-1 H-pyrrole

Synthesis and Biological Activity of 2-Alkylbenzimidazoles Bearing a N-phenylpyrrole Moiety As Novel Angiotensin II AT1 Receptor Antagonists

Synthesis of 5-amido-1H-imidazo[5,4-b]pyridine derivatives and their angiotensin II receptor antagonistic activities

Design, Synthesis and Biological Evaluation of 6-Substituted Aminocarbonyl Benzimidazole Derivatives As Nonpeptidic Angiotensin II AT1 Receptor Antagonists.

Design and Synthesis of 2-Alkylbenzimidazole Derivatives As Novel Non-Peptide Angiotensin II AT1 Receptor Antagonists

Synthesis and Biological Evaluation of 4 '-[(Benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide Derivatives As Dual Angiotensin Ii/Endothelin A Receptor Antagonists

Synthesis And Biological Activities Of 4-Substituted-3-Alky-4,5-Dihydro-1-(3-Chloro-4-Fluorophenyl)-1,2,4-Triaz Ol-5-One Derivatives

Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor.

Structural Insights into Angiotensin Receptor Signaling Modulation by Balanced and Biased Agonists.

Discovery of Novel, Potent and Low-Toxicity Angiotensin Ii Receptor Type 1 (at(1)) Blockers: Design, Synthesis and Biological Evaluation of 6-Substituted Aminocarbonyl Benzimidazoles with A Chiral Center

QSAR studies of angiotensin II AT1 receptor antagonists

Design, Synthesis, and Biological Evaluation of 1,2,4-Triazole Bearing 5-Substituted Biphenyl-2-sulfonamide Derivatives As Potential Antihypertensive Candidates

Synthesis and in Vitro Evaluation of Ambrisentan Analogues As Potential Endothelin Receptor Antagonists.

Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT 1 receptor antagonists

Characterization of Angiotensin II Antagonism Displayed by Ib, a Novel Nonpeptide Angiotensin AT1 Receptor Antagonist

Synthesis and Biological Evaluations of Novel Nitric Oxide-donating Derivatives of [1,2,4]triazol-5(4H)-one with N-phenylpyrrolyl-2-tetrazole Moiety as Anti-hypertension Candidates

Synthesis and Biological Activity of 1-(1,4-benzodioxan-2-yl-carbonyl)-4-aryloxy-alkyl-piperazine As Α_1-Adrenoceptor Antagonists

Synthesis and Biological Evaluation of 4′-[(Benzimidazol-1-yl) Methyl]biphenyl-2-amides As Dual Angiotensin II and Endothelin A Receptor Antagonists

Design, Synthesis, and Biological Evaluation of Benzofuran Derivatives As ET Receptor Antagonists

Design, Synthesis, and Bioactivity of Pyrazole Acid Derivatives As Endothelin Receptor Antagonists

Synthesis and blocking activities of a new class of α₁-adrenoceptor antagonists.